These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19161279)

  • 1. A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor.
    Heitman LH; Göblyös A; Zweemer AM; Bakker R; Mulder-Krieger T; van Veldhoven JP; de Vries H; Brussee J; Ijzerman AP
    J Med Chem; 2009 Feb; 52(4):926-31. PubMed ID: 19161279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor.
    Göblyös A; Gao ZG; Brussee J; Connestari R; Santiago SN; Ye K; Ijzerman AP; Jacobson KA
    J Med Chem; 2006 Jun; 49(11):3354-61. PubMed ID: 16722654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.
    Gao ZG; Verzijl D; Zweemer A; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    Biochem Pharmacol; 2011 Sep; 82(6):658-68. PubMed ID: 21718691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor.
    Kim Y; de Castro S; Gao ZG; Ijzerman AP; Jacobson KA
    J Med Chem; 2009 Apr; 52(7):2098-108. PubMed ID: 19284749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists.
    Zhu R; Frazier CR; Linden J; Macdonald TL
    Bioorg Med Chem Lett; 2006 May; 16(9):2416-8. PubMed ID: 16487705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000.
    Deganutti G; Cuzzolin A; Ciancetta A; Moro S
    Bioorg Med Chem; 2015 Jul; 23(14):4065-71. PubMed ID: 25868747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.
    Colotta V; Capelli F; Lenzi O; Catarzi D; Varano F; Poli D; Vincenzi F; Varani K; Borea PA; Dal Ben D; Volpini R; Cristalli G; Filacchioni G
    Bioorg Med Chem; 2009 Jan; 17(1):401-10. PubMed ID: 18996701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
    Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A
    Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences and mechanism of action of A
    Du L; Gao ZG; Paoletta S; Wan TC; Gizewski ET; Barbour S; van Veldhoven JPD; IJzerman AP; Jacobson KA; Auchampach JA
    Purinergic Signal; 2018 Mar; 14(1):59-71. PubMed ID: 29170977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands.
    Ravn J; Qvortrup K; Rosenbohm C; Koch T
    Bioorg Med Chem; 2007 Aug; 15(16):5440-7. PubMed ID: 17560111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.
    van den Nieuwendijk AM; Pietra D; Heitman L; Göblyös A; IJzerman AP
    J Med Chem; 2004 Jan; 47(3):663-72. PubMed ID: 14736246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
    Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
    J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Trolling to Optimize A
    Pradhan B; Pavan M; Fisher CL; Salmaso V; Wan TC; Keyes RF; Rollison N; Suresh RR; Kumar TS; Gao ZG; Smith BC; Auchampach JA; Jacobson KA
    J Med Chem; 2024 Jul; 67(14):12221-12247. PubMed ID: 38959401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
    Biagi G; Bianucci AM; Coi A; Costa B; Fabbrini L; Giorgi I; Livi O; Micco I; Pacchini F; Santini E; Leonardi M; Nofal FA; Salerni OL; Scartoni V
    Bioorg Med Chem; 2005 Aug; 13(15):4679-93. PubMed ID: 15908217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.